Plasma markers in pulmonary hypertension subgroups correlate with patient survival

Autor: T. Koudstaal, D. van Uden, J. A. C. van Hulst, P. Heukels, I. M. Bergen, L. W. Geenen, V. J. M. Baggen, A. E. van den Bosch, L. M. van den Toorn, P. P. Chandoesing, M. Kool, E. Boersma, R. W. Hendriks, K. A. Boomars

Publikováno v: Respiratory Research, Vol 22, Iss 1, Pp 1-13 (2021)

Abstract Background Recent studies have provided evidence for an important contribution of the immune system in the pathophysiology of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). In this report, we

Externí odkaz: https://doaj.org/article/5f628a5ac8dd448486f8bea92b62db59

The longitudinal use of EmPHasis-10 and CAMPHOR questionnaire health-related quality of life scores in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Autor: Monique Wapenaar, M C J Van Thor, M.C. Post, K. A. Boomars, Paul M. Hendriks, L M van den Toorn, A E Van Den Bosch, Prewesh Chandoesing

Publikováno v: European Heart Journal. 42

Background Health-related quality of life (HRQoL) is impaired in patients with pulmonary hypertension (PH). The EmPHasis-10 and CAMPHOR questionnaires are developed to evaluate HRQoL specifically in patients with PH. Data on the longitudinal use of b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cea576983cc90f0318225c7b6ea354ec
https://doi.org/10.1093/eurheartj/ehab724.1959

Additional file 1 of Plasma markers in pulmonary hypertension subgroups correlate with patient survival

Autor: T. Koudstaal, D. Van Uden, J. A. C. Van Hulst, P. Heukels, I. M. Bergen, L. W. Geenen, V. J. M. Baggen, A. E. Van Den Bosch, L. M. Van Den Toorn, P. P. Chandoesing, M. Kool, E. Boersma, R. W. Hendriks, K. A. Boomars

Additional file 1: Figure 1. Effects of CXCL9 and IL-8 plasma levels on patient survival. Figure 2. Plasma concentrations of IL-1β and IL-6 Inflammatory markers in plasma of PAH and CTEPH patients at diagnosis and 1-year follow up. Figure 3. Inflamm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::475c4a4b0555f160de36886d2acb5aa8

Needs, Perceptions and Education in Sarcoidosis: A Live Interactive Survey of Patients and Partners

Autor: J. A. M. van Laar, Jelle R. Miedema, Catharina C. Moor, A. P. C. Berendse, M. J. G. van Manen, Y. Gür-Demirel, Marlies S. Wijsenbeek, L M van den Toorn, P M van Hagen

Publikováno v: Lung
Lung, 196(5), 569-575. Springer New York

Objectives Sarcoidosis is a chronic, multisystem disease with often a major impact on quality of life. Information on unmet needs of patients and their partners is lacking. We assessed needs and perceptions of sarcoidosis patients and their partners.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00f052aef2e0207698096ae4a956f2b6
https://doi.org/10.1007/s00408-018-0144-4

Adaptation and validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Netherlands

Autor: K. A. Boomars, A. Heaney, J. Stepanous, P. Seijkens, Monique Wapenaar, L M van den Toorn, A E Van Den Bosch, M. Wagenaar, J. Twiss

Publikováno v: Netherlands Heart Journal, 24(6), 417-424. Bohn Stafleu van Loghum
Wapenaar, M, Twiss, J, Wagenaar, M, Seijkens, P, van den Toorn, L, Stepanous, J, Heaney, A, van den Bosch, A & Boomars, K A 2016, ' Adaptation and validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Netherlands ', Netherlands Heart Journal, vol. 24, no. 6, pp. 417-424 . https://doi.org/10.1007/s12471-016-0849-z
Netherlands Heart Journal

The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) is the first disease-specific instrument for pulmonary arterial hypertension (PAH) to assess patient-perceived symptoms, activity limitations and quality of life. To be able to use this qu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d4b726d7598cb1cfe822db759a8793e
https://doi.org/10.1007/s12471-016-0849-z